Jury Still Out On "Inherent Anticipation"

Law360, New York (April 17, 2005, 12:00 AM EDT) -- On April 8, 2005, a “public use” case died and, from its ashes, an “inherent anticipation” case arose. On that day the Federal Circuit, en banc, over the dissent of Judge Newman, vacated the “experimental use” portion of the original panel decision in SmithKline Beecham Corp. v. Apotex Corp., 365 F.3d 1306 (Fed. Cir. 2004) (“SKB I”), and remanded to the panel for further proceedings. SmithKline Beecham Corp. v. Apotex Corp., Nos. 03-1285, -1313, 2005 WL 788426 (Fed. Cir. Apr. 8, 2005)(en banc order and dissenting...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.